Asong, Junessa B.

HRN: 22-89-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2023
CEFUROXIME 500MG (TAB)
04/23/2023
04/30/2023
PO
500mg
BID X 7days
2nd Degree Perineorrhaphy; Thickly Meconium Stained Amniotic Fluid
Waiting Final Action 
04/23/2023
METRONIDAZOLE 500MG (TAB)
04/23/2023
04/30/2023
PO
500mg
BID X 7 Days
2nd Degree Perineorrhaphy; Thickly Meconium Stained Amniotic Fluid
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: